Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1982 Jul;49(1):200–208.

Evaluation of aggregated IgG in mice as an Fc receptor specific probe of the hepatic mononuclear phagocyte system.

R A Jimenez, M Mannik
PMCID: PMC1536660  PMID: 7127898

Abstract

In experimental models of immune complex diseases the hepatic mononuclear phagocyte system removes circulating immune complexes (CIC) by interaction with Fc receptors, and the spleen has a relatively insignificant role in this function. We have used heat-aggregated human IgG (AHGG) to detect altered hepatic mononuclear phagocyte system activity in an acute immune complex model in mice in order to evaluate its suitability for possible use in humans. Immune complexes inhibited the clearance of AHGG, as a function of the dose and of the time after injection of complexes. The delayed clearance resulted from decreased hepatic uptake of the AHGG. Alterations in the comparatively small splenic uptake of AHGG did not correlate with changes in the clearance or the hepatic uptake that were produced by the complexes. Studies with Rose Bengal showed that the complexes caused a small but definite decrease in hepatic blood flow. Immune complexes also inhibited the clearance and hepatic uptake of aggregated mouse albumin and aggregated ovalbumin. The aggregated albumins, however, were cleared very rapidly, indicating high extraction ratios, so their clearance was more affected by the decreased blood flow than the clearance of AHGG. We conclude that a small dose of AHGG is a sensitive probe for hepatic Fc receptor function and has potential for human use.

Full text

PDF
200

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Briner W. H. Preparation of 125I-labeled microaggregated human serum albumin for use in studies of reticuloendothelial function in man. J Nucl Med. 1968 Sep;9(9):482–485. [PubMed] [Google Scholar]
  2. Emlen W., Mannik M. Effect of preformed immune complexes on the clearance and tissue localization of single-stranded DNA in mice. Clin Exp Immunol. 1980 May;40(2):264–272. [PMC free article] [PubMed] [Google Scholar]
  3. Frank M. M., Hamburger M. I., Lawley T. J., Kimberly R. P., Plotz P. H. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med. 1979 Mar 8;300(10):518–523. doi: 10.1056/NEJM197903083001002. [DOI] [PubMed] [Google Scholar]
  4. HELMKAMP R. W., GOODLAND R. L., BALE W. F., SPAR I. L., MUTSCHLER L. E. High specific activity iodination of gamma-globulin with iodine-131 monochloride. Cancer Res. 1960 Nov;20:1495–1500. [PubMed] [Google Scholar]
  5. Haakenstad A. O., Mannik M. Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol. 1974 May;112(5):1939–1948. [PubMed] [Google Scholar]
  6. Haakenstad A. O., Mannik M. The disappearance kinetics of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest. 1976 Sep;35(3):283–292. [PubMed] [Google Scholar]
  7. Hamburger M. I., Moutsopoulos H. M., Lawley T. J., Frank M. M. Sjögren's syndrome: a defect in reticuloendothelial system Fc-receptor-specific clearance. Ann Intern Med. 1979 Oct;91(4):534–538. doi: 10.7326/0003-4819-91-4-534. [DOI] [PubMed] [Google Scholar]
  8. Hupf H. B., Wanek P. M., O'Brien H. A., Jr, Holland L. M. Rapid radioiodination of rose bengal at room temperature. J Nucl Med. 1978 May;19(5):525–529. [PubMed] [Google Scholar]
  9. Kamme C., Cöster C., Hagelquist E., Kalén N., Lindholm H., Grubb R. Side effects of treatment of hypogammaglobulinaemia with gammaglobulin. Acta Med Scand. 1966 Jun;179(6):679–690. doi: 10.1111/j.0954-6820.1966.tb05493.x. [DOI] [PubMed] [Google Scholar]
  10. Klaassen C. D. Pharmacokinetics of rose bengal in the rat, rabbit, dog and guinea pig. Toxicol Appl Pharmacol. 1976 Oct;38(1):85–100. doi: 10.1016/0041-008x(76)90163-0. [DOI] [PubMed] [Google Scholar]
  11. Klausner M. A., Hirsch L. J., Leblond P. F., Chamberlain J. K., Klemperer M. R., Segel G. B. Contrasting splenic mechanisms in the blood clearance of red blood cells and colloidal particles. Blood. 1975 Dec;46(6):965–976. [PubMed] [Google Scholar]
  12. Lawrence S., Lockwood C. M., Peters D. K. Studies on NEM-treated erythrocyte clearance in the rabbit, with special reference to the effects of circulating immune complexes. Clin Exp Immunol. 1981 May;44(2):433–439. [PMC free article] [PubMed] [Google Scholar]
  13. Lockwood C. M., Worlledge S., Nicholas A., Cotton C., Peters D. K. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med. 1979 Mar 8;300(10):524–530. doi: 10.1056/NEJM197903083001003. [DOI] [PubMed] [Google Scholar]
  14. Mauer S. M., Fish A. J., Blau E. B., Michael A. F. The glomerular mesangium. I. Kinetic studies of macromolecular uptake in normal and nephrotic rats. J Clin Invest. 1972 May;51(5):1092–1101. doi: 10.1172/JCI106901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Munthe-Kaas A. C., Kaplan G., Seljelid R. On the mechanism of internalization of opsonized particles by rat Kupffer cells in vitro. Exp Cell Res. 1976 Nov;103(1):201–212. doi: 10.1016/0014-4827(76)90256-1. [DOI] [PubMed] [Google Scholar]
  16. Nishi T., Bhan A. K., Collins A. B., McCluskey R. T. Effect of circulating immune complexes on Fc and C3 receptors of Kupffer cells in vivo. Lab Invest. 1981 May;44(5):442–448. [PubMed] [Google Scholar]
  17. Ropars C., Caldera L. H., Griscelli C., Homberg J. C., Salmon C. Anti-immunoglobulin antibodies in immunodeficiencies: their influence on intolerance reactions to gamma-globulin administration. Vox Sang. 1974;27(4):294–301. doi: 10.1111/j.1423-0410.1974.tb02422.x. [DOI] [PubMed] [Google Scholar]
  18. Theofilopoulos A. N., Wilson C. B., Dixon F. J. The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest. 1976 Jan;57(1):169–182. doi: 10.1172/JCI108257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wilkinson G. R., Shand D. G. Commentary: a physiological approach to hepatic drug clearance. Clin Pharmacol Ther. 1975 Oct;18(4):377–390. doi: 10.1002/cpt1975184377. [DOI] [PubMed] [Google Scholar]
  20. Winkler K., Larsen J. A., Munkner T., Tygstrup N. Determination of the hepatic blood flow in man by simultaneous use of five test substances measured in two parts of the liver. Scand J Clin Lab Invest. 1965;17(5):423–432. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES